HERON ELAINE J
SEC insider (Form 3/4/5 filer). CIK 0001235471. Director at Vaxart, Inc. (VXRT) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies HERON ELAINE J has filed insider reports for
- Vaxart, Inc. (VXRT): Director
- PALVELLA THERAPEUTICS, INC. (PVLA): Director
HERON ELAINE J
CIK: 0001235471
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jul 16, 2026VXRT
Vaxart, Inc.
AwardDirect39.4K shares- - Jun 10, 2026PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
3K shares- - Feb 27, 2026PVLA
PALVELLA THERAPEUTICS, INC.
PurchaseDirect2.4K shares at avg. $125.00$300K - Nov 17, 2025VXRT
Vaxart, Inc.
PurchaseDirect23.2K shares at avg. $0.39$9K - Nov 17, 2025VXRT
Vaxart, Inc.
PurchaseDirect16.8K shares at avg. $0.41$7K - Jun 13, 2025VXRT
Vaxart, Inc.
AwardDirect16K shares- - Jun 10, 2025PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectNon-Qualified Stock Option (right to buy)
12.4K shares- - Dec 13, 2024PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
24.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  VXRT Vaxart, Inc. | Award | 39,400 | - | $0 | Direct |
| Jun 10, 2026 |  PVLA PALVELLA THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 3,000 | - | - | Direct |
| Feb 27, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Purchase | 2,400 | $125.00 | $300,000 | Direct |
| Nov 17, 2025 | VXRT Vaxart, Inc. | Purchase | 23,217 | $0.39 | $9,124 | Direct |
| Nov 17, 2025 | VXRT Vaxart, Inc. | Purchase | 16,783 | $0.41 | $6,797 | Direct |
| Jun 13, 2025 | VXRT Vaxart, Inc. | Award | 16,000 | - | - | Direct |
| Jun 10, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | Award Non-Qualified Stock Option (right to buy) | 12,350 | - | - | Direct |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 24,700 | - | - | Direct |
1-8 of 8 transactions